NCT02409108View on ClinicalTrials.gov

Perfusion-Induced Hyperthermia for Metastatic Carcinoma

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

February 16, 2019

Conditions
Metastatic Non-Small Cell Lung CarcinomaSolid Tumor, Adult
Interventions
DEVICE

Exatherm-TBH system

One treatment of Total Body Hyperthermia

Trial Locations (1)

40536

University of Kentucky, Markey Cancer Center, Lexington

All Listed Sponsors
collaborator

Exatherm, Inc

INDUSTRY

lead

Jonathan Kiev

OTHER

NCT02409108 - Perfusion-Induced Hyperthermia for Metastatic Carcinoma | Biotech Hunter | Biotech Hunter